About our client
Zymeworks Inc. is a publicly held biotechnology company based in Vancouver, British Columbia, that develops protein therapeutics for the treatment of cancer as well as for autoimmune and inflammatory diseases.
About our client
R1 is a leading provider of technology-enabled revenue cycle management services which transform a health system’s revenue cycle performance across settings of care.
About our client
RedBrick Health is a health technology and services company based in Minneapolis, Minnesota. RedBrick Health is privately held and works with large, self-insured employers, progressive health plans, providers and accountable care organizations.
About our client
Bellicum is a clinical stage biopharmaceutical company focused on discovering and developing cellular immunotherapies for cancers and orphan inherited blood disorders.
About our client
Icon Bioscience Inc. (IBI) a privately held specialty biopharma company, is pioneering a transformational change in the delivery of ophthalmic pharmaceuticals by focusing on the development and commercialization of novel intraocular therapeutics based on our proprietary and patented drug delivery platform, Verisome®.
About our client
Over the last 40 plus years, Radiology Associates of Florida has expanded its practice to 53 Board certified radiologists’ who sub-specialize in all sub specialties of radiology.
About our client
Leap Therapeutics is developing targeted and immuno-oncology therapeutics. Leap’s most advanced clinical candidate, DKN-01, is a humanized monoclonal antibody targeting the Dickkopf-1 (DKK1) protein, a Wnt pathway modulator.
About our client
Alphatec Holdings, Inc., through its wholly-owned subsidiary of Alphatec Spine, Inc., is a medical device company that designs, develops and markets spinal fusion technology products and solutions for the treatment of spinal disorders associated with disease and degeneration, congenital deformities and trauma.
About our client
Adverum is a clinical-stage gene therapy company targeting unmet medical needs in serious rare and ocular diseases.
About our client
Viveve designs, develops, manufactures and markets a medical device for the non-invasive treatment of vaginal introital laxity, for improved sexual function, for vaginal rejuvenation, and for use in general surgery for electrocoagulation and hemostasis.
About our client
Office Practicum is a top ranked provider of electronic health record and practice management software for use in ambulatory primary care settings.
About our client
Sol-Gel is a clinical-stage dermatology company focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases.
About our client
Montagu is one of Europe's longest standing private equity firms and has been successfully investing in leading mid-market businesses for nearly fifty years.
About our client
Leap Therapeutics is developing targeted and immuno-oncology therapeutics. Leap’s most advanced clinical candidate, DKN-01, is a humanized monoclonal antibody targeting the Dickkopf-1 (DKK1) protein, a Wnt pathway modulator.
About our client
ConnectiveRx was formed in late 2015 by bringing together PSKW, pioneers in affordability solutions, and PDR, innovators in advanced adherence communications products.
About our client
ADMA is a late-stage biopharmaceutical company that develops, manufactures and intends to commercialize specialty plasma-based biologics for the proposed treatment of Primary Immune Deficiency Disease (PIDD) and the prevention and treatment of certain infectious diseases.
About our client
American Addiction Centers is a leading provider of inpatient substance abuse treatment services. The company treats adults as well as adolescents who are struggling with drug addiction, alcohol addiction, and co-occurring mental/behavioral health issues.
About our client
Corbus Pharmaceuticals Holdings, Inc. is a Phase 3 clinical stage pharmaceutical company focused on the development and commercialization of novel therapeutics to treat rare, chronic, and serious inflammatory and fibrotic diseases.
About our client
BioTime is a late stage clinical biotechnology company focused on developing and commercializing products addressing degenerative diseases. The Company’s current clinical programs are targeting three primary sectors, aesthetics, ophthalmology and cell/drug delivery.
About our client
Flexion is a specialty pharmaceutical company focused on the development and commercialization of novel, local therapies for the treatment of patients with musculoskeletal conditions, beginning with osteoarthritis (“OA”).
About our client
Juno Therapeutics is building a fully integrated biopharmaceutical company focused on developing innovative cellular immunotherapies for the treatment of cancer.
About our client
Florida Anesthesia Associates P.A is a group of highly qualified Physician Anesthesiologists formed in 1994 to provide organized single group anesthesia coverage to Baptist Medical Center Jacksonville in Jacksonville, FL.
About our client
Florida Anesthesia Associates and Jacksonville Anesthesia Corporation comprise over 50 clinicians who provide inpatient and outpatient anesthesia services in Northeast Florida to Baptist Health System and other clinical sites across a wide-range of surgical subspecialties including neuroendovascular, cardiac, vascular, electrophysiologic & structural cardiology, orthopedic, otolaryngology, and ophthalmology.
About our client
Healthcare Bluebook works with employers to make healthcare price and quality transparency available to their employees and directly via our website and mobile apps to provide Fair Price™ information to everyone.
About our client
BHT Group, including BHT Hygienetechnik and ESCAD Medical, is the leading German company for reprocessing of endoscopes and medical instruments.
About our client
EGI is a medical device company that designs, develops and commercializes a range of non-invasive neurodiagnostic products used to monitor and interpret brain activity.
About our client
BioTelemetry, Inc. is the leading wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care.
About our client
CENTOGENE AG provides test portfolios of over 3,100 single genes and over 200 panels. The company is currently receiving samples from over 110 countries, with approximately 120,000 analyzed individuals in its database, CentoMD®.
About our client
Akebia Therapeutics, Inc. is a biopharmaceutical company. The Company focuses on the development and commercialization of therapeutics based on hypoxia-inducible factor (HIF) biology.
About our client
Qvella is a molecular diagnostics company founded in 2009 by a group of scientists and engineers with the goal of dramatically reducing time to results in bacteriology.
About our client
PLx Pharma Inc. is a late-stage specialty pharmaceutical company focused on developing its clinically validated and patent-protected PLxGuard™ delivery system to provide safe and effective aspirin products.
About our client
GenMark Diagnostics is a molecular diagnostics company focused on developing and commercializing high-value, simple to perform, clinically relevant multiplex molecular tests based on the Company’s proprietary eSensor electrochemical detection technology.
About our client
ADMA is a late-stage biopharmaceutical company that develops, manufactures and intends to commercialize specialty plasma-based biologics for the proposed treatment of Primary Immune Deficiency Disease (PIDD) and the prevention and treatment of certain infectious diseases.
About our client
Founded in 2004, RPS Diagnostics (RPS) is an emerging developer, manufacturer, and marketer of rapid point-of-care diagnostic tests.
About our client
Founded in 1988, CranialTech is a leading developer, manufacturer and provider of medical devices and services for the treatment of positional plagiocephaly in infants. The Company’s mission is to provide a superior product, service, and the best possible outcome for every child with an abnormal head shape.
About our client
Flexion is a specialty pharmaceutical company focused on the development and commercialization of novel, local therapies for the treatment of patients with musculoskeletal conditions, beginning with osteoarthritis (“OA”).
About our client
UroGen Pharma Ltd. operates as a clinical stage biopharmaceutical company. The Company focuses on developing novel therapies designed to change the standard of care for urological pathologies with a focus on uro-oncology.
About our client
Renal Ventures Management, LLC provides dialysis care and information for people living with chronic kidney disease in the United States.
About our client
Epigenomics, Inc. operates as a biotechnology company which develops novel products for cancer. The company’s products include validated biomarker for the early detection of colorectal cancer in blood plasma, proprietary DNA methylation biomarkers for prostate and lung cancer detection in urine, blood and bronchial lavage specimens.
About our client
Adamis Pharmaceuticals Corporation is a specialty biopharmaceutical company focused on developing and commercializing products in the therapeutic areas of respiratory disease and allergy.
About our client
Formed in 2014 via the merger of two regional hospice providers, today the Care Hospice platform operates in eight states and serves over 830 patients daily.
About our client
ALung Technologies, Inc. is a privately-held Pittsburgh-based developer and manufacturer of innovative lung assist devices. Founded in 1997 as a spin-out of the University of Pittsburgh, ALung has developed the Hemolung RAS as a dialysis-like alternative or supplement to mechanical ventilation.
About our client
Blueprint Medicines is developing a new generation of targeted and potent kinase medicines to improve the lives of patients with genomically defined diseases.
About our client
Founded in 1987, Merit Medical Systems, Inc. is engaged in the development, manufacture and distribution of proprietary disposable medical devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology and endoscopy.
About our client
Bellicum is a clinical stage biopharmaceutical company focused on discovering and developing cellular immunotherapies for cancers and orphan inherited blood disorders.
About our client
Vital Therapies, Inc. is a biotherapeutic company developing a cell-based therapy targeting the treatment of acute forms of liver failure. The Company’s ELAD System is an extracorporeal human allogeneic cellular liver therapy currently in phase 3 clinical trials.
About our client
Viveve designs, develops, manufactures and markets a medical device for the non-invasive treatment of vaginal introital laxity, for improved sexual function, for vaginal rejuvenation, and for use in general surgery for electrocoagulation and hemostasis.
About our client
Aerpio Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing first-in-class treatments for ocular diseases. The Company’s lead program, AKB-9778, is a small molecule activator of the Tie2 pathway and is in clinical development for diabetic retinopathy.
About our client
Medical Optics is the industry leader for equipment, endoscope and instrument repair including complete restoration needs. Since its launch in 1997, every piece of equipment has been repaired with expert precision and unparalleled care at a state-of-the art facility.
About our client
Headquartered in the Research Park at Florida Atlantic University, MobileHelp is a leading provider of mobile Personal Emergency Response Systems (PERS) and health management solutions.
